Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
  1. 4/A Open-market buy Director bought 5,000 shares at $6.90 ($34,500)
  2. 4 Grant or award Director acquired 5,000 shares (grant or award)
  3. 4 Open-market buy Chief Financial Officer bought 1,500 shares at $7.04 ($10,560)
  4. 4 Open-market buy Chief Medical Officer bought 2,836 shares at $7.00 ($19,852)
  5. 4 Open-market buy Director bought 10,000 shares at $7.08 ($70,800)
  6. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $7.17 ($7,169)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy Chief Medical Officer bought 2,479 shares at $6.05 ($14,998)
  10. 4 Open-market buy Chief Executive Officer bought 1,695 shares at $6.00 ($10,170)
  11. 4 Open-market buy Chief Financial Officer bought 2,500 shares at $5.91 ($14,775)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market buy Chief Financial Officer bought 3,300 shares at $6.14 ($20,262)
  17. 4 Open-market buy Director bought 500 shares at $6.23 ($3,115)
  18. 4 Open-market buy Director bought 3,400 shares at $6.18 ($21,012)
  19. 4 Open-market buy Director bought 5,000 shares at $6.15 ($30,741)
  20. 4 Open-market buy Chief Medical Officer bought 2,435 shares at $6.12 ($14,905)

Page 11 of 17 · 340 filings